Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Limitations and Confusing Aspects of Diagnostic Testing for Neurologic Lyme Disease in the United States.

Theel ES, Aguero-Rosenfeld ME, Pritt B, Adem PV, Wormser GP.

J Clin Microbiol. 2019 Jan 2;57(1). pii: e01406-18. doi: 10.1128/JCM.01406-18. Print 2019 Jan. Review.

2.

Rapid and Extensive Expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, Sequence Type 1193.

Tchesnokova VL, Rechkina E, Larson L, Ferrier K, Weaver JL, Schroeder DW, She R, Butler-Wu SM, Aguero-Rosenfeld ME, Zerr D, Fang FC, Ralston J, Riddell K, Scholes D, Weissman S, Parker K, Spellberg B, Johnson JR, Sokurenko EV.

Clin Infect Dis. 2019 Jan 7;68(2):334-337. doi: 10.1093/cid/ciy525.

3.

Emergence and Evolution of Multidrug-Resistant Klebsiella pneumoniae with both blaKPC and blaCTX-M Integrated in the Chromosome.

Huang W, Wang G, Sebra R, Zhuge J, Yin C, Aguero-Rosenfeld ME, Schuetz AN, Dimitrova N, Fallon JT.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00076-17. doi: 10.1128/AAC.00076-17. Print 2017 Jul.

4.

Lyme disease: diagnostic issues and controversies.

Aguero-Rosenfeld ME, Wormser GP.

Expert Rev Mol Diagn. 2015 Jan;15(1):1-4. doi: 10.1586/14737159.2015.989837. Epub 2014 Dec 8. Review.

PMID:
25482091
5.

Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.

Wormser GP, Tang AT, Schimmoeller NR, Bittker S, Cooper D, Visintainer P, Aguero-Rosenfeld ME, Ogrinc K, Strle F, Stanek G.

Med Microbiol Immunol. 2014 Feb;203(1):65-71. doi: 10.1007/s00430-013-0315-0. Epub 2013 Nov 12.

PMID:
24218117
6.

Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Wormser GP, Aguero-Rosenfeld ME, Cox ME, Nowakowski J, Nadelman RB, Holmgren D, McKenna D, Bittker S, Zentmaier L, Cooper D, Liveris D, Schwartz I, Horowitz HW.

J Clin Microbiol. 2013 Mar;51(3):954-8. doi: 10.1128/JCM.02929-12. Epub 2013 Jan 9.

7.

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Wormser GP, Schriefer M, Aguero-Rosenfeld ME, Levin A, Steere AC, Nadelman RB, Nowakowski J, Marques A, Johnson BJ, Dumler JS.

Diagn Microbiol Infect Dis. 2013 Jan;75(1):9-15. doi: 10.1016/j.diagmicrobio.2012.09.003. Epub 2012 Oct 11.

8.

Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity.

Horowitz HW, Aguero-Rosenfeld ME, Holmgren D, McKenna D, Schwartz I, Cox ME, Wormser GP.

Clin Infect Dis. 2013 Jan;56(1):93-9. doi: 10.1093/cid/cis852. Epub 2012 Oct 5.

PMID:
23042964
9.

Vertical transmission of Babesia microti, United States.

Joseph JT, Purtill K, Wong SJ, Munoz J, Teal A, Madison-Antenucci S, Horowitz HW, Aguero-Rosenfeld ME, Moore JM, Abramowsky C, Wormser GP.

Emerg Infect Dis. 2012 Aug;18(8):1318-21. doi: 10.3201/eid1808.110988.

10.

2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.

Branda JA, Aguero-Rosenfeld ME, Ferraro MJ, Johnson BJ, Wormser GP, Steere AC.

Clin Infect Dis. 2010 Jan 1;50(1):20-6. doi: 10.1086/648674.

PMID:
19947857
11.

Polyphyletic emergence of linezolid-resistant staphylococci in the United States.

Wong A, Reddy SP, Smyth DS, Aguero-Rosenfeld ME, Sakoulas G, Robinson DA.

Antimicrob Agents Chemother. 2010 Feb;54(2):742-8. doi: 10.1128/AAC.00621-09. Epub 2009 Nov 23.

12.

Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease.

Wormser GP, Nowakowski J, Nadelman RB, Visintainer P, Levin A, Aguero-Rosenfeld ME.

Clin Vaccine Immunol. 2008 Oct;15(10):1519-22. doi: 10.1128/CVI.00109-08. Epub 2008 Aug 20.

13.

Lyme disease: laboratory issues.

Aguero-Rosenfeld ME.

Infect Dis Clin North Am. 2008 Jun;22(2):301-13, vii. doi: 10.1016/j.idc.2007.12.005. Review.

PMID:
18452803
14.

Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis.

Wormser GP, Filozov A, Telford SR 3rd, Utpat S, Kamer RS, Liveris D, Wang G, Zentmaier L, Schwartz I, Aguero-Rosenfeld ME.

Vector Borne Zoonotic Dis. 2006 Winter;6(4):388-94.

PMID:
17187574
15.

Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease.

Bryksin AV, Godfrey HP, Carbonaro CA, Wormser GP, Aguero-Rosenfeld ME, Cabello FC.

Clin Diagn Lab Immunol. 2005 Aug;12(8):935-40.

16.

Diagnosis of lyme borreliosis.

Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP.

Clin Microbiol Rev. 2005 Jul;18(3):484-509. Review.

17.

In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis.

Bayard-Mc Neeley M, Bansal A, Chowdhury I, Girao G, Small CB, Seiter K, Nelson J, Liveris D, Schwartz I, Mc Neeley DF, Wormser GP, Aguero-Rosenfeld ME.

J Clin Pathol. 2004 May;57(5):499-503.

18.

Diagnosis of human granulocytic ehrlichiosis: state of the art.

Aguero-Rosenfeld ME.

Vector Borne Zoonotic Dis. 2002 Winter;2(4):233-9. Review.

PMID:
12804164
19.

Laboratory aspects of tick-borne diseases: lyme, human granulocytic ehrlichiosis and babesiosis.

Aguero-Rosenfeld ME.

Mt Sinai J Med. 2003 May;70(3):197-206. Review.

PMID:
12764539
20.

Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients.

Lin Q, Zhi N, Ohashi N, Horowitz HW, Aguero-Rosenfeld ME, Raffalli J, Wormser GP, Rikihisa Y.

J Clin Microbiol. 2002 Aug;40(8):2981-8.

21.

Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York.

Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L, Jacob J, Frey M, Noto R, Carbonaro CA, Wormser GP.

J Clin Microbiol. 2002 Jul;40(7):2612-5.

22.

Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques.

Nowakowski J, Schwartz I, Liveris D, Wang G, Aguero-Rosenfeld ME, Girao G, McKenna D, Nadelman RB, Cavaliere LF, Wormser GP; Lyme Disease Study Group.

Clin Infect Dis. 2001 Dec 15;33(12):2023-7. Epub 2001 Nov 7.

PMID:
11700579
23.

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite.

Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, McKenna D, Welch P, Marcus R, Agüero-Rosenfeld ME, Dennis DT, Wormser GP; Tick Bite Study Group.

N Engl J Med. 2001 Jul 12;345(2):79-84.

24.

Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis.

Bakken JS, Aguero-Rosenfeld ME, Tilden RL, Wormser GP, Horowitz HW, Raffalli JT, Baluch M, Riddell D, Walls JJ, Dumler JS.

Clin Infect Dis. 2001 Mar 15;32(6):862-70. Epub 2001 Mar 7.

PMID:
11247709
25.

Antimicrobial susceptibility of Ehrlichia phagocytophila.

Horowitz HW, Hsieh TC, Aguero-Rosenfeld ME, Kalantarpour F, Chowdhury I, Wormser GP, Wu JM.

Antimicrob Agents Chemother. 2001 Mar;45(3):786-8.

26.

Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions.

Kalantarpour F, Chowdhury I, Wormser GP, Aguero-Rosenfeld ME.

J Clin Microbiol. 2000 Jun;38(6):2398-9.

27.

A limitation of 2-stage serological testing for Lyme disease: enzyme immunoassay and immunoblot assay are not independent tests.

Wormser GP, Carbonaro C, Miller S, Nowakowski J, Nadelman RB, Sivak S, Aguero-Rosenfeld ME.

Clin Infect Dis. 2000 Mar;30(3):545-8.

PMID:
10722442
28.

Serology of culture-confirmed cases of human granulocytic ehrlichiosis.

Aguero-Rosenfeld ME, Kalantarpour F, Baluch M, Horowitz HW, McKenna DF, Raffalli JT, Hsieh Tc, Wu J, Dumler JS, Wormser GP.

J Clin Microbiol. 2000 Feb;38(2):635-8.

29.

Serum cytokine responses during acute human granulocytic ehrlichiosis.

Dumler JS, Trigiani ER, Bakken JS, Aguero-Rosenfeld ME, Wormser GP.

Clin Diagn Lab Immunol. 2000 Jan;7(1):6-8.

30.

Failure of a lipid amphotericin B preparation to eradicate candiduria: preliminary findings based on three cases.

Agustin J, Lacson S, Raffalli J, Aguero-Rosenfeld ME, Wormser GP.

Clin Infect Dis. 1999 Sep;29(3):686-7. No abstract available.

PMID:
10530471
31.

Effects of OspA vaccination on Lyme disease serologic testing.

Aguero-Rosenfeld ME, Roberge J, Carbonaro CA, Nowakowski J, Nadelman RB, Wormser GP.

J Clin Microbiol. 1999 Nov;37(11):3718-21.

32.

Lyme disease serology: problems and opportunities.

Wormser GP, Aguero-Rosenfeld ME, Nadelman RB.

JAMA. 1999 Jul 7;282(1):79-80. No abstract available.

PMID:
10404917
33.

Clinical and laboratory evolution of a culture-confirmed case of human granulocytic ehrlichiosis.

Hossain D, Aguero-Rosenfeld ME, Horowitz HW, Wu JM, Hsieh TC, Sachdeva N, Peterson SJ, Dumler JS, Wormser GP.

Conn Med. 1999 May;63(5):265-70.

PMID:
10363404
34.

Changes in expression of the 44-kilodalton outer surface membrane antigen (p44 kD) for monitoring progression of infection and antimicrobial susceptibility of the human granulocytic ehrlichiosis (HGE) agent in HL-60 cells.

Hsieh T, DiPietrantonio AM, Horowitz HW, Dumler JS, Aguero-Rosenfeld ME, Wormser GP, Wu JM.

Biochem Biophys Res Commun. 1999 Apr 13;257(2):351-5.

PMID:
10198216
35.

Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia.

Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, Maraspin V, Aguero-Rosenfeld ME, Varde S, Lotric-Furlan S, Wormser GP.

Ann Intern Med. 1999 Jan 5;130(1):32-6.

PMID:
9890847
36.

Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases.

Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, Holmgren D, Hsieh TC, Varde SA, Dumler SJ, Wu JM, Schwartz I, Rikihisa Y, Wormser GP.

Clin Infect Dis. 1998 Nov;27(5):1314-7.

PMID:
9827289
37.

Cell cycle effects and induction of apoptosis caused by infection of HL-60 cells with human granulocytic ehrlichiosis pathogen measured by flow and laser scanning cytometry.

Bedner E, Burfeind P, Hsieh TC, Wu JM, Aguero-Rosenfeld ME, Melamed MR, Horowitz HW, Wormser GP, Darzynkiewicz Z.

Cytometry. 1998 Sep 1;33(1):47-55.

PMID:
9725558
38.

Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis.

Nadelman RB, Horowitz HW, Hsieh TC, Wu JM, Aguero-Rosenfeld ME, Schwartz I, Nowakowski J, Varde S, Wormser GP.

N Engl J Med. 1997 Jul 3;337(1):27-30. No abstract available.

39.

Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE).

Hsieh TC, Aguero-Rosenfeld ME, Wu JM, Ng C, Papanikolaou NA, Varde SA, Schwartz I, Pizzolo JG, Melamed M, Horowitz HW, Nadelman RB, Wormser GP.

Biochem Biophys Res Commun. 1997 Mar 17;232(2):298-303.

PMID:
9125168
40.

Human granulocytic ehrlichiosis: a case series from a medical center in New York State.

Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, McKenna DF, Nowakowski J, Muñoz J, Dumler JS.

Ann Intern Med. 1996 Dec 1;125(11):904-8.

PMID:
8967671
41.

Accuracy of IgM immunoblotting to confirm the clinical diagnosis of early Lyme disease.

Sivak SL, Aguero-Rosenfeld ME, Nowakowski J, Nadelman RB, Wormser GP.

Arch Intern Med. 1996 Oct 14;156(18):2105-9.

PMID:
8862103
42.

Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.

Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP.

J Clin Microbiol. 1996 Jan;34(1):1-9.

43.

Serodiagnosis in early Lyme disease.

Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP.

J Clin Microbiol. 1993 Dec;31(12):3090-5. Erratum in: J Clin Microbiol 1994 Mar;32(3):860.

44.

Infection of adult Syrian hamsters with flagellar variants of Campylobacter jejuni.

Aguero-Rosenfeld ME, Yang XH, Nachamkin I.

Infect Immun. 1990 Jul;58(7):2214-9.

Supplemental Content

Loading ...
Support Center